COSCIENS Biopharma Inc. (CSCI): key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2025)
- $7.5M
- Net Income/Loss (FY2025)
- -$10.4M
- Total Assets (FY2025)
- $21.4M
- Total Equity (FY2025)
- $3.8M
- Cash Flows from Operating Activities (FY2025)
- -$8.5M
Source: COSCIENS Biopharma Inc. 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
